DALFAMPRIDINE | DALFAMPRIDINE | ATC N07XX07
NERVOUS SYSTEM MULTIPLE SCLEROSIS BROAD SPECTRUM POTASSIUM ION CHANNELS INHIBITOR (KV) INDICATED TO IMPROVE WALKING IN PATIENTS WITH MULTIPLE SCLEROSIS (MS) | ORAL | Cmax 0.318 MICROMOLAR (10 MILLIGRAM) F 96 PERCENT VD 169 LITER (65 KILOGRAM) PPB 98 PERCENT Cl 20 LITER / HOUR (EQN) HT 5.8 HOUR SOLUBILITY SOLUBLE IN WATER | SHAKER KCNA | VOLTAGE-GATED POTASSIUM CHANNEL BLOCKER CHEMBL2362996 VOLTAGE-GATED POTASSIUM CHANNEL O43525 POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY KQT MEMBER 3 HOMO SAPIENS ION CHANNEL VGC K VG K | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |